ERBB2 and breast carcinoma: Visualization of the selected biomarkers on different breast cancer subtypes showed the expected distinct expression patterns for HER2+ [Fig. 6(a)], HER2−, ER− [Fig. 6(b)], and ER+ [Fig. 6(c)] breast cancers.